← Back to directory

Ron T. Gansevoort

Researcher Next ID · RN-023416

Researcher · Medicine

University Medical Center Groningen

Groningen, Netherlands

Not currently recruitingFunding unknown
Works count
827
Citation count
74,699
H-index
118
i10-index
523

Research interests

Medicine
Biochemistry, Genetics and Molecular Biology
Chronic Kidney Disease and Diabetes
Dialysis and Renal Disease Management
Genetic and Kidney Cyst Diseases
Blood Pressure and Hypertension Studies
Renal Diseases and Glomerulopathies

Publications

  • SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe

    European Heart Journal · 2021 · https://doi.org/10.1093/eurheartj/ehab309

  • Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference

    Kidney International · 2020 · https://doi.org/10.1016/j.kint.2020.02.010

  • The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

    Kidney International · 2020 · 10.1016/j.kint.2020.10.012

  • Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency

    American Journal of Kidney Diseases · 2019 · 10.1053/j.ajkd.2019.06.009

  • A catalog of genetic loci associated with kidney function from analyses of a million individuals

    Nature Genetics · 2019 · https://doi.org/10.1038/s41588-019-0407-x

  • World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions

    The Lancet Global Health · 2019 · https://doi.org/10.1016/s2214-109x(19)30318-3

  • The Association of Obesity and Cardiometabolic Traits With Incident HFpEF and HFrEF

    JACC Heart Failure · 2018 · 10.1016/j.jchf.2018.05.018

  • Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy

    The Lancet · 2017 · 10.1016/s0140-6736(17)30788-2

  • Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease

    New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1710030

  • Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk

    Nature Genetics · 2017 · 10.1038/ng.3768

  • CKD Prevalence Varies across the European General Population

    Journal of the American Society of Nephrology · 2015 · 10.1681/asn.2015050542

  • Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data

    The Lancet Diabetes & Endocrinology · 2015 · 10.1016/s2213-8587(15)00040-6

  • Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy

    JAMA · 2015 · 10.1001/jama.2015.10081

  • Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

    Kidney International · 2015 · 10.1038/ki.2015.59

  • Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality

    JAMA · 2014 · 10.1001/jama.2014.6634

  • Cystatin C versus Creatinine in Determining Risk Based on Kidney Function

    New England Journal of Medicine · 2013 · 10.1056/nejmoa1214234

  • Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND

    European Heart Journal · 2013 · 10.1093/eurheartj/eht066

  • Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention

    The Lancet · 2013 · https://doi.org/10.1016/s0140-6736(13)60595-4

  • Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

    New England Journal of Medicine · 2012 · https://doi.org/10.1056/nejmoa1205511

  • Age and Association of Kidney Measures With Mortality and End-stage Renal Disease

    JAMA · 2012 · 10.1001/jama.2012.16817

  • Comparison of Risk Prediction Using the CKD-EPI Equation and the MDRD Study Equation for Estimated Glomerular Filtration Rate

    JAMA · 2012 · 10.1001/jama.2012.3954

  • Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts

    Kidney International · 2011 · 10.1038/ki.2010.536

  • Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts

    Kidney International · 2011 · 10.1038/ki.2010.531

  • Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts

    Kidney International · 2011 · 10.1038/ki.2010.550

  • The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report

    Kidney International · 2010 · https://doi.org/10.1038/ki.2010.483

Current projects

    No projects listed.